Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272928 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL7751077 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4933530 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4931890 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4927093 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL8756384 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4932566 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4930730 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL4926580 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 | |
| SCHEMBL8756462 | 0.98 | USP2 (0.62) | USP2HTTSPHK1LPAR5MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170204077-A1 | Method of Producing Epoxy Compound and Catalyst Composition for Epoxidation Reaction | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-07-20 | — | — | US | claimed |
| CN-104203933-A | Process for producing epoxy compound and catalyst composition for epoxidation reaction | MITSUBISHI CHEM CORP | 2014-12-10 | — | — | CN | claimed |
| US-6019925-A | TERTIARY AMINE OXIDE | AKZO NOBEL NV (NL) | 2000-02-01 | — | — | US | claimed |
| EP-0807460-A1 | Cellulosic dialysis membrane | Akzo Nobel N.V. (NL) | 1997-11-19 | — | — | EP | claimed |
| EP-0352863-A2 | 1,4-Dihydropyridine dicarboxylic acid derivatives | ZAMBON GROUP S.p.A. (IT) | 1990-01-31 | — | — | EP | claimed |
| EP-0065864-B1 | ANTI-HYPERTENSIVE 1-SUBSTITUTED SPIRO (PIPERIDINE-OXOBENZOXAZINES) | SYNTEX (U.S.A.) INC. (US) | 1985-08-28 | — | — | EP | claimed |
| EP-0065864-A1 | Anti-hypertensive 1-substituted spiro (piperidine-oxobenzoxazines) | SYNTEX (U.S.A.) INC. (US) | 1982-12-01 | — | — | EP | claimed |
| US-4349549-A | Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s | SYNTEX (U.S.A.) INC. (US) | 1982-09-14 | — | — | US | claimed |
| EP-0005318-A1 | N-Heterocyclyl-4-piperidinamines, methods for their preparation, pharmaceutical compositions comprising them, intermediates therefor, and method for the preparation of the intermediates | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-11-14 | — | — | EP | claimed |
| JP-2078661-A | — | — | None | — | — | JP | disclosed |
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-113166036-B | Photopolymerizing sensitizers with migration resistance | 川崎化成工业株式会社 | 2023-10-10 | — | — | CN | disclosed |
| CN-115128901-A | Photosensitive resin composition, cured product, printed wiring board, and method for producing printed wiring board | 太阳油墨制造株式会社 | 2022-09-30 | — | — | CN | disclosed |
| CN-114763453-A | Surface protective film, optical member including the same, and display apparatus including the same | 三星SDI株式会社 | 2022-07-19 | — | — | CN | disclosed |
| EP-0065864-A1 | Anti-hypertensive 1-substituted spiro (piperidine-oxobenzoxazines) | SYNTEX (U.S.A.) INC. (US) | 1982-12-01 | — | — | EP | disclosed |
| US-4349549-A | Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s | SYNTEX (U.S.A.) INC. (US) | 1982-09-14 | — | — | US | disclosed |
| US-4349549-A | Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s | SYNTEX (U.S.A.) INC. (US) | 1982-09-14 | — | — | US | disclosed |
| US-4219559-A | N-Heterocyclyl-4-piperidinamines | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-08-26 | — | — | US | disclosed |
| US-4181802-A | ADRENERGIC BLOCKING AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-01-01 | — | — | US | disclosed |
| EP-0005610-A2 | 1-(Heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, their preparation, their pharmaceutical compositions and their use as beta-adrenergic receptor blockers | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958802-B2 | Migration-resistant photopolymerization sensitizer | F12, F10, PCNA | USP2 2545/4885HTT 1272/4885SPHK1 1796/4885 |
| US-20170204077-A1 | Method of Producing Epoxy Compound and Catalyst Composition for Epoxidation Reaction | EPX, MPO, NOX5 | USP2 2237/4885HTT 4462/4885SPHK1 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.